Literature DB >> 15717881

An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study.

A M Aas1, I Bergstad, P M Thorsby, O Johannesen, M Solberg, K I Birkeland.   

Abstract

AIMS: The aims of this study were to assess whether, in Type 2 diabetic patients with inadequate glycaemic control on oral hypoglycaemic agents (OHA), a lifestyle intervention programme based on exercise and diet counselling (i) was as effective as insulin treatment in controlling blood glucose, and (ii) could prevent the weight gain usually accompanying the introduction of insulin treatment.
METHODS: Thirty-eight Type 2 diabetic subjects treated with OHA, HbA(1c) 8-10.5% and body mass index (BMI) 26-40 kg/m2, were randomized to the following treatments: (i) lifestyle intervention (L), (ii) lifestyle intervention + insulin treatment (L+I) and (iii) insulin treatment alone (I).
RESULTS: There was a reduction in HbA(1c) of -1.2 (interquartile range 1.0), -1.0 (1.7) and -1.5 (2.5)% in group L, L+I and I, respectively, and all treatment groups achieved beneficial changes in blood lipid variables. There was no significant difference between the groups in the change observed in levels of HbA(1c) between start and 12 months of treatment (P = 0.74). There was a significant difference in weight changes between groups (P < 0.01): group L reduced weight by median -3.0 (4.0) kg, groups L+I and I increased weight by 3.5 (3.4) and 4.9 (6.9) kg, respectively.
CONCLUSIONS: Lifestyle intervention was as effective as insulin treatment in improving glycaemic control in poorly controlled subjects with Type 2 diabetes, and resulted in weight loss during the intervention year. However, glycaemic control deteriorated and body weight increased in the lifestyle intervention group 1 year after the intervention stopped.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717881     DOI: 10.1111/j.1464-5491.2005.01421.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

Review 1.  [Metabolic surgery or conservative measures as therapy of obese type 2 diabetics?]

Authors:  Udo Jahn; Thomas Schubert; Sibylle Schlepp; Heinz Jürgen Deuber
Journal:  Wien Med Wochenschr       Date:  2016-12-05

2.  Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment--Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial.

Authors:  Kirsten J Coppell; Minako Kataoka; Sheila M Williams; Alex W Chisholm; Sue M Vorgers; Jim I Mann
Journal:  BMJ       Date:  2010-07-20

3.  Description of clinical risk factor changes during naturopathic care for type 2 diabetes.

Authors:  Ryan Bradley; Eva Kozura; Heather Buckle; Jennifer Kaltunas; Setareh Tais; Leanna J Standish
Journal:  J Altern Complement Med       Date:  2009-06       Impact factor: 2.579

4.  Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes.

Authors:  A-M Aas; I Seljeflot; P A Torjesen; L M Diep; P M Thorsby; K I Birkeland
Journal:  Diabetologia       Date:  2006-03-23       Impact factor: 10.122

Review 5.  Individual patient education for people with type 2 diabetes mellitus.

Authors:  Sally-Anne S Duke; Stephen Colagiuri; Ruth Colagiuri
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

6.  The effect of behaviour change interventions on changes in physical activity and anthropometrics in ambulatory hospital settings: a systematic review and meta-analysis.

Authors:  Stephen Barrett; Stephen Begg; Paul O'Halloran; Owen Howlett; Jack Lawrence; Michael Kingsley
Journal:  Int J Behav Nutr Phys Act       Date:  2021-01-07       Impact factor: 6.457

7.  Improvement of glycemic control after re-emphasis of lifestyle modification in type 2 diabetic patients reluctant to additional medication.

Authors:  Hee Jin Kim; Tae Sik Jung; Jung Hwa Jung; Soo Kyoung Kim; Sang Min Lee; Kyong Young Kim; Deok Ryong Kim; Yeong Mi Seo; Jong Ryeal Hahm
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

8.  Insulin for type 2 diabetes: choosing a second-line insulin regimen.

Authors:  A Barnett; A Begg; P Dyson; M Feher; S Hamilton; N Munro
Journal:  Int J Clin Pract       Date:  2008-11       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.